Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/1999
06/09/1999CN1218692A Novel Anti-spasmodic composition and process for manufacture thereof
06/09/1999CN1043576C Pyrido (1,2,3-de) quinoxaline derivatives, process for preparing the same and their use in medicine
06/09/1999CN1043575C Silylated acetylcholinesterase inhibitors
06/09/1999CN1043574C Heterocyclic amines having central nervous system activity
06/08/1999US5910593 Highly selective process for the preparation of enantiomerically pure phenylsubstituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives
06/08/1999US5910586 Tricyclic aminoalkylcarboxamides; dopamine D3 receptor subtype specific ligands
06/08/1999US5910574 Human trk receptors and neurotrophic factor inhibitors
06/08/1999US5910502 Use of levobupivacaine in paediatric surgery
06/08/1999US5910501 Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolozin-3(4H)-one and related compounds for treating cognitive disorders
06/08/1999US5910430 Isolated nucleic acid encoding G-protein coupled receptor (HTADX50)
06/08/1999US5910319 Superior single dose formulation of the antidepressant drug, layer comprising hydroxypropylmethylcellulose acetate succinates
06/08/1999US5910307 Process of extracting and purifying biologically effective ingredients from combined medicinal plants and their extract composition
06/08/1999US5910301 Method of intrapulmonary administration of a narcotic drug
06/08/1999CA2242308A1 Novel compounds
06/03/1999WO1999027098A2 A-33 related antigens and their pharmacological uses
06/03/1999WO1999027095A1 Human cdc10 homolog
06/03/1999WO1999026942A1 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability
06/03/1999WO1999026927A2 Metabotropic glutamate receptor antagonists for treating central nervous system diseases
06/03/1999WO1999026924A1 Substituted oximes as neurokinin antagonists
06/03/1999WO1999026661A1 A covalent conjugate of clozapine with a fatty acid and its use for treating schizophrenia
06/03/1999WO1999026651A1 ribH
06/03/1999WO1999026650A1 ribB
06/03/1999WO1999026646A1 ribA
06/03/1999WO1999026633A1 Citicoline to treat motor neuron diseases and demyelinating diseases
06/03/1999WO1999026631A1 Methods for treating postmenopausal women using ultra-low doses of estrogen
06/03/1999WO1999026630A1 Testosterone inhibitors and use for the protection of neurons
06/03/1999WO1999026626A1 Spheroids containing tiagabine, preparation process and pharmaceutical compositions
06/03/1999WO1999026625A1 Formulations comprising dissolved paroxetine
06/03/1999WO1999026621A1 Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration
06/03/1999WO1999026620A1 Choline esters of fatty acids and their use in the treatment of stroke
06/03/1999WO1999026616A1 Benzenesulfonamide inhibitors of pde-iv and their therapeutic use
06/03/1999WO1999026614A1 Substituted 2-aminoacetamides and the use thereof
06/03/1999WO1999010312B1 N-alkanoylphenylalanine derivatives
06/03/1999WO1999007729A3 Peptides having potassium channel opener activity
06/03/1999WO1999002502A3 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation
06/03/1999CA2311498A1 Choline esters of fatty acids and their use in the treatment of stroke
06/03/1999CA2311422A1 Citicoline to treat motor neuron diseases and demyelinating diseases
06/03/1999CA2311131A1 Metabotropic glutamate receptor antagonists for treating central nervous system diseases
06/03/1999CA2311126A1 Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration
06/03/1999CA2310540A1 Human cdc10 homolog
06/03/1999CA2309855A1 Testosterone inhibitors and use for the protection of neurons
06/03/1999CA2309358A1 A-33 related antigens and their pharmacological uses
06/02/1999EP0919550A1 Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride
06/02/1999EP0919541A1 Naphthalene compounds, process for their preparation and their pharmaceutical compositions
06/02/1999EP0919245A2 NK-1 receptor antagonist and a systemic antiinflammatory corticosteroid for the treatment of emesis
06/02/1999EP0919236A1 Use of a norepinephrine uptake inhibitor for the treatment of oppositional defiant disorder
06/02/1999EP0919235A1 Use of a norepinephrine reuptake inhibitor for the treatment of conduct disorder
06/02/1999EP0919234A2 Potentiation of pharmaceuticals by moxonidine
06/02/1999EP0918857A1 Human induced tumor protein
06/02/1999EP0918856A2 Two human nsp-like proteins
06/02/1999EP0918777A1 SELECTED DERIVATIVES OF K-252a
06/02/1999EP0918772A1 Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2(1h)-indol-2-one (=ziprasidone), its preparation and its use as dopamine d2 antagonist
06/02/1999EP0918771A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase
06/02/1999EP0918767A1 Pharmaceutical for treating of neurological and neuropsychiatric disorders
06/02/1999EP0918522A1 Antagonists of gonadotropin releasing hormone
06/02/1999EP0918521A1 Formulation for the treatment and/or prophylaxis of dementia
06/02/1999EP0918455A1 Galanin
06/02/1999EP0845036B1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
06/02/1999EP0757718A4 Methods of use of uncoated gel particles
06/02/1999EP0630376B1 Condensed indole derivatives as 5-ht4-receptor antagonists
06/02/1999EP0593692B1 Process for the preparation of ergoline derivatives
06/02/1999EP0579681B1 Crystalline tiagabine hydrochloride monohydrate, its preparation and use
06/02/1999EP0548254B1 6- or 7-(imidazolidin-2-ylideneamino)-1,4-benzoxazines as alpha adrenergic agents
06/02/1999CN1218464A 2,3 disulbstituted-4 (3H)-quinazolinones
06/02/1999CN1218461A Alkylaminobenzothiazole and -benzoxazole derivatives
06/02/1999CN1218409A Stimulation of host defence mechanisms against viral challenges
06/02/1999CN1218395A Buccal delivery system
06/02/1999CN1218052A New indole and indazole compounds, process for their preparation and pharmaceutical compositions containing them
06/02/1999CN1218051A New 2,3-dioxide, indanol compounds, process for their preparation and pharmaceutical compositions containing them
06/02/1999CN1218047A Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
06/02/1999CN1043532C The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy
06/01/1999US5908860 4-carbonylamino-substituted-2,2-dimethyl-3,4-dihydrobenzopyran -3-ols
06/01/1999US5908851 Derivatives of succinamide and their use as metalloproteinase inhibitor
06/01/1999US5908848 Analgesics
06/01/1999US5908847 The new combination confers a synergistic effect, and provides unexpected efficacy
06/01/1999US5908846 Topical compositions for transdermal delivery of prodrug derivatives of morphine
06/01/1999US5908844 Neuroleptic agent
06/01/1999US5908843 Thrombosis, antiinflammatory agent, arteriosclerosis, antitumor agents
05/1999
05/27/1999WO1999025716A2 Pyranones, method for the production and use thereof
05/27/1999WO1999025714A1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists
05/27/1999WO1999025710A1 Imidazole derivatives, preparation and therapeutic application thereof
05/27/1999WO1999025709A1 Isoquinoline derivatives and their therapeutical use
05/27/1999WO1999025695A1 5-arylpyrazole compounds
05/27/1999WO1999025693A1 Metalloproteinase inhibitors
05/27/1999WO1999025687A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
05/27/1999WO1999025686A1 Cyclic amine derivatives and their use as drugs
05/27/1999WO1999025364A1 Method for treating attention deficit disorder
05/27/1999WO1999025363A1 Combination of active principles, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia
05/27/1999WO1999025356A1 Use of mirtazapine for treating sleep apneas
05/27/1999WO1999025354A2 Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters
05/27/1999WO1999025348A1 5-ht1f agonists
05/27/1999WO1999025340A1 Treatment for alzheimer's disease
05/27/1999WO1999025339A1 Treatment for alzheimer's disease
05/27/1999WO1999025337A1 Composition of ingredients for a beverage having a delayed aversion effect
05/27/1999WO1999014346A3 SENSE mRNA THERAPY
05/27/1999WO1999013908A9 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent
05/27/1999WO1999012961A8 Estrogen receptor
05/27/1999WO1999012529A3 Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience
05/27/1999WO1999010480A3 New tissue-specific calpaines, their production and their use
05/27/1999WO1999003817A3 Aliphatic propargylamines as cellular rescue agents
1 ... 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 ... 1833